MKI67 and neoplasm: This prospective study was conducted to examine the effectiveness of a therapeutic strategy that switches drugs during treatment, according to the biological tumour response at interim Ki-67 assessment, compared with the existing strategy, in which a continuous predetermined chemotherapy regimen is administered.